Dna Testing Centers (DNAT) Gross Profit Margin starting from the fourth quarter 2018 to fourth quarter 2017, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Dna Testing Centers Corp  (DNAT)


Dna Testing Centers's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNAT Gross Profit Margin (Dec 31 2018)
Q4 		(Dec 31 2017)
Q4 		(Sep 30 2017)
Q3 		(Jun 30 2017)
Q2 		(Mar 31 2017)
Q1
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-0.01
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2018 Gross Profit Margin
Learn about Gross Margin
DNAT's Gross Profit Margin fourth quarter 2018 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
88.25 % 49.82 % 20.49 %
(Mar 31 2017)   (Sep 30 2017)


DNAT Gross Income Trends • More of DNAT's Profitabilty Ratios • DNAT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
DNAT's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DNAT's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DNAT's Competitors
Gross Profit Margin Profit Margin for Dna Testing Centers's Suppliers
Gross Profit Margin Profit Margin for DNAT's Customers

You may also want to know
DNAT's Annual Growth Rates DNAT's Profitability Ratios DNAT's Asset Turnover Ratio DNAT's Dividend Growth
DNAT's Roe DNAT's Valuation Ratios DNAT's Financial Strength Ratios DNAT's Gross Profit Growth
DNAT's Roa DNAT's Inventory Turnover Ratio DNAT's Growth Rates DNAT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2018, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginDec 31 2018 MRQ Gross ProfitDec 31 2018 MRQ Revenue
Immunomedics Inc   93.54 %$ 1.007  Millions$ 1.076  Millions
Navidea Biopharmaceuticals Inc   80.87 %$ 0.096  Millions$ 0.119  Millions
Myriad Genetics Inc   79.70 %$ 172.800  Millions$ 216.800  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.